Cargando…
FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity
Rationale: Mesenchymal cell-derived osteosarcoma is a rare malignant bone tumor affecting children and adolescents. PTEN down-regulation or function-loss mutation is associated with the aggressive of osteosarcoma. Explicating the regulatory mechanism of PTEN might highlight new targets for improving...
Autores principales: | Wu, Wei, Jing, Doudou, Meng, Zibo, Hu, Binwu, Zhong, Binlong, Deng, Xiangyu, Jin, Xin, Shao, Zengwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052884/ https://www.ncbi.nlm.nih.gov/pubmed/32194840 http://dx.doi.org/10.7150/thno.41279 |
Ejemplares similares
-
Bruceine D inhibits tumor growth and stem cell‐like traits of osteosarcoma through inhibition of STAT3 signaling pathway
por: Wang, Shangyu, et al.
Publicado: (2019) -
Integrative analysis of immune‐related multi‐omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma
por: Shi, Deyao, et al.
Publicado: (2022) -
LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
por: Shi, Deyao, et al.
Publicado: (2019) -
Correction to: LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
por: Shi, Deyao, et al.
Publicado: (2020) -
Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma
por: Shi, Deyao, et al.
Publicado: (2021)